CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. today announced the pricing of its initial public offering of 5,500,000 shares of its common stock at a public offering price of $12.00 per share, before underwriting discounts. In addition, Genocea has granted the underwriters a 30-day option to purchase up to an additional 825,000 shares of common stock at the same price to cover over-allotments, if any. The shares are scheduled to begin trading on the NASDAQ Global Market on February 5, 2014 under the ticker symbol “GNCA."
Help employers find you! Check out all the jobs and post your resume.
